New tuberculosis technologies: importance of access in the private health sector
By Keynote ContributorProf. Madhu Pai, MDCanada Research Chair in Epidemiology & Global Health,McGill University, Montreal By Prof Madhukar Pai Cepheid Inc., produces Xpert MTB/RIF, which is an automated, fast test for TB using molecular diagnostics. Compared to the standard test for TB in developing countries, sputum smear microscopy, it is considerably more accurate. In an hour and a half, Xpert […]
Continue reading »